1. 163 Genetic Modifiers in Carriers of the SCN5A E1784K Mutation with Variable Phenotypic Expression - Long QT3 / Brugada Syndrome Overlap Disease. (31st May 2014) Authors: Dullewe Wijeyeratne, Yanushi; Muggenthaler, Martina; Tanck, Michael W; Schott, Jean-Jacques; Kyndt, Florence; Probst, Vincent; Borggrefe, Martin; McKeown, Pascal; Veltmann, Christian; Crotti, Lia; Schwartz, Peter; Sharma, Sanjay; Makita, Naomasa; Roden, Dan; Behr, Elijah R Journal: Heart Issue: Volume 100:(2014)Supplement 3 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Building a Central Repository for Research Ethics Consultation Data: A Proposal for a Standard Data Collection Tool. Issue 4 (10th March 2015) Authors: Cho, Mildred K.; Taylor, Holly; McCormick, Jennifer B.; Anderson, Nick; Barnard, David; Boyle, Mary B.; Capron, Alexander M.; Dorfman, Elizabeth; Havard, Kathryn; Reider, Carson; Sadler, John; Schwartz, Peter; Sharp, Richard R.; Danis, Marion; Wilfond, Benjamin S. Journal: Clinical and translational science Issue: Volume 8:Issue 4(2015) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of Lymphedema Incidence Between 2 Lymphadenectomy Techniques in Patients With Uterine Cancer Undergoing Robotic Staging. Issue 1 (1st January 2015) Authors: Menderes, Gulden; Azodi, Masoud; Schwartz, Peter; Silasi, Dan-Arin Journal: International journal of gynecological cancer Issue: Volume 25:Issue 1(2015:Jan.) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of Lymphedema Incidence Between 2 Lymphadenectomy Techniques in Patients With Uterine Cancer Undergoing Robotic Staging. Issue 1 (January 2015) Authors: Menderes, Gulden; Azodi, Masoud; Schwartz, Peter; Silasi, Dan-Arin Journal: International journal of gynecological cancer Issue: Volume 25:Issue 1(2015:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EGFR/HER-targeted therapeutics in ovarian cancer. (March 2012) Authors: Wilken, Jason A; Badri, Tayf; Cross, Sarah; Raji, Rhoda; Santin, Alessandro D; Schwartz, Peter; Branscum, Adam J; Baron, Andre T; Sakhitab, Adam I; Maihle, Nita J Journal: Future medicinal chemistry Issue: Volume 4:Number 4(2012) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EGFR/HER-targeted therapeutics in ovarian cancer. (March 2012) Authors: Wilken, Jason A; Badri, Tayf; Cross, Sarah; Raji, Rhoda; Santin, Alessandro D; Schwartz, Peter; Branscum, Adam J; Baron, Andre T; Sakhitab, Adam I; Maihle, Nita J Journal: Future medicinal chemistry Issue: Volume 4:Number 4(2012) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EGFR/HER-targeted therapeutics in ovarian cancer. (March 2012) Authors: Wilken, Jason A; Badri, Tayf; Cross, Sarah; Raji, Rhoda; Santin, Alessandro D; Schwartz, Peter; Branscum, Adam J; Baron, Andre T; Sakhitab, Adam I; Maihle, Nita J Journal: Future medicinal chemistry Issue: Volume 4:Number 4(2012) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EP007/#994 Bay 1895344, a novel ATR inhibitor, demonstrates in vivo activity against ATRX altered uterine leiomyosarcoma. (4th December 2022) Authors: Harold, Justin; Manavella, Diego; Bellone, Stefania; Siegel, Eric; Hartwich, Tobias; Zammataro, Luca; Mutlu, Levent; Altwerger, Gary; Menderes, Gulden; Ratner, Elena; Huang, Gloria; Clark, Mitchell; Andikyan, Vaagn; Azodi, Masoud; Schwartz, Peter; Alexandrov, Ludmil; Santin, Alessandro Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro. Issue 1 (December 2015) Authors: Ferrari, Francesca; Bellone, Stefania; Black, Jonathan; Schwab, Carlton; Lopez, Salvatore; Cocco, Emiliano; Bonazzoli, Elena; Predolini, Federica; Menderes, Gulden; Litkouhi, Babak; Ratner, Elena; Silasi, Dan-Arin; Azodi, Masoud; Schwartz, Peter; Santin, Alessandro Journal: Journal of experimental & clinical cancer research Issue: Volume 34:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Structure and mechanics of textile fibre assemblies. (2019) Editors: Schwartz, Peter Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗